The first head-to-head comparison of therapeutic monoclonal antibodies produced from plants versus the same antibodies produced from mammalian cells has shown that plant-produced antibodies can fight infection equally well.
Scientists from Washington University School of Medicine in St. Louis and Arizona State University conducted the comparison as a test of the potential for treating disease in developing nations with the significantly less expensive plant-based production technique.